Interleukin-10 reduces morbidity and mortality in murine multiple organ dysfunction syndrome (MODS)

Journal of Surgical Research

Volumn 77, Issue 2, 1998, Pages 157-164

  Ferrer, T J ^a   Webb, J W ^a   Wallace, B H ^a   Bridges, C D ^a   Palmer, H E ^a   Robertson, R D ^a   Cone, J B ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Interleukin 10; MODS; Multiple organ dysfunction syndrome; Zymosan

Indexed keywords

BILIRUBIN; CREATININE; INTERLEUKIN 10; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; IMMUNOPHARMACOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG COMPLIANCE; MALE; MORBIDITY; MORTALITY; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL;

EID: 0032123524     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5372     Document Type: Article

References (42)

1. Baue A. E. Multiple Organ Failure: Patient Care and Prevention. 1990;Mosby-Year Book, St. Louis.
2. Zimmerman J. E., Knaus W. A., Sun X., Wagner D. P. Severity stratification and outcome prediction for multisystem organ failure and dysfunction. World J. Surg. 20:1996.
3. Baue A. E. The horror autotoxicus and multiple-organ failure. Arch. Surg. 127:1992;1451.
4. Sauaia A., Moore F. A., Moore E. E., Haenel J. B., Read R. A., Lezotte D. C. Early predictors of postinjury multiple organ failure. Arch. Surg. 129:1994;39.
5. Fein A. M., Abraham E. M., Balk R. A., Bernard G. R., Bone R. C., Dantzker D. R., Fink M. P. Sepsis and Multiorgan Failure. 1997;Williams & Wilkins, Baltimore.
6. Bone R. C. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: What we do and do not known about cytokine regulation. Crit. Care Med. 24:1996;163.
7. Goris R. J. A. MODS/SIRS: Result of an overwhelming inflammatory response. World J. Surg. 20:1996;418.
8. Ertel W., Keel M., Steckholzer U., Ungethuem U., Trentz O. Interleukin-10 attenuates the release of proinflammatory cytokines but depresses splenocyte functions in murine endotoxemia. Arch. Surg. 131:1996;51.
9. de Vries J. E. Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann. Med. 27:1995;537.
10. Rennick D., Berg D., Holland G. Interleukin 10: An overview. Prog. Growth Factor Res. 4:1992;207.
11. Fiorentino D. F., Zlotnik A., Mosmann T. R. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:1991;3815.
12. de Waal M. R., Yssel J., de Vries J. C. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. J. Immunol. 150:1993;4754.
13. Cox G. IL-10 enhances resolution of pulmonary inflammation in vivo by promoting apoptosis of neutrophils. Am. J. Physiol. 271:1996;L566.
14. Cassatella M. A., Meda L., Bonora S., Ceska M., Constantin G. IL-10 inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide. J. Exp. Med. 178:1993;2207.
15. Howard M., Muchamuel T., Andrade S., Menon S. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1993;1205.
16. Gerard C., Bruyns C., Marchant A., Abramowicz D., Vandenabeele P., Delvaux A., Fiers W., Goldman M., Velu T. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:1993;547.
17. Kato T., Murata A., Ishida H., Toda H., Tanaka N., Hayashida H., Monden M., Matsuura N. Interleukin 10 reduces mortality from severe peritonitis in mice. Antimicrob. Agents Chemother. 39:1995;1336.
18. Bean A. G. D., Freiberg R. A., Andrade S., Menon S., Zlotnik A. Interleukin 10 protects mice against staphylococcal enteroxin b-induced lethal shock. Infect. Immun. 61:1993;4937.
19. Kusske A. M., Rongione A. J., Ashley S. W., Mcfadden D. W., Reber H. A. Interleukin-10 prevents death in lethal necrotizing pancreatitis in mice. Surgery. 120:1996;284.
20. Goris R. J. A., Boekholtz W. K. F., van Bebber I. P. T., Nuytinck J. K. S., Schillings P. H. M. Multiple-organ failure and sepsis without bacteria. Arch. Surg. 121:1986;897.
21. Steinberg S., Flynn W., Kelley K., Bitzer L., Sharma P., Gutierrez C., Baxter J., Lalka D., Sands A., Van Liew J., Hassett J., Price R., Beam T., Flint L. Development of a bacteria-independent model of the multiple organ failure syndrome. Arch. Surg. 124:1989;1390.
22. Joyce L. D., Hau T., Hoffman R., Simmons R. L., Lillehei R. C. Evaluation of the mechanism of zymosan-induced resistance to experimental peritonitis. Surgery. 83:1978;717.
23. Schirmer W. J., Schirmer J. M., Naff G. B., Fry D. E. Alternative pathway complement activation induces reductions in effective hepatic blood flow. Curr. Surg. July-Aug:1987;304.
24. Von Asmuth E. J. U., Maessen J. G., Van Der Linden C. J., Buurman W. A. Tumour necrosis factor alpha (TNF-α) and interleukin-6 in a zymosan-induced shock model. Scand. J. Immunol. 32:1990;313.
25. Deitch E. A., Specian R. D., Grisham M. B., Berg R. D. Zymosan-induced bacterial translocation: A study of mechanisms. Crit. Care Med. 20:1992;782.
26. Nieuwenhuijzen G. A. P., Haskel Y., Lu Q., Berg R. D., van Rooijen N., Goris R. J. A., Deitch E. A. Macrophage elimination increases bacterial translocation and gut-origin septicemia but attenuates symptoms and mortality rate in a model of systemic inflammation. Ann. Surg. 218:1993;791.
27. Torok K., Nemeth K., Erdo F., Aranyi P., Szekely J. I. Measurement and drug induced modulation of interleukin-1 level during zymosan peritonitis in mice. Inflamm. Res. 44:1995;248.
28. Nieuwenhuijzen G. A. P., Meyer M. P. D., Hendriks T., Goris R. J. A. Deficiency of complement factor C5 reduces early mortality but does not prevent organ damage in an animal model of multiple organ dysfunction syndrome. Crit. Care Med. 23:1995;1686.
29. Jansen M. J. J. M., Hendriks T., Verhofstad A. A. J., Lange W., Geeraedts L. M. G., Goris R. J. A. Gradual development of organ damage in the murine zymosan-induced multiple organ dysfunction syndrome. Shock. 8:1997;261.
30. Jansen M. J. J. M., Hendriks T., Vogels M. T. C., van der Meer J. W. M., Goris R. J. A. Inflammatory cytokines in an experimental model for the multiple organ dysfunction syndrome. Crit. Care Med. 24:1996;1196.
31. Deitch E. A., Kemper A. C., Specian R. D., Berg R. D. A study of the relationships among survival, gut-origin sepsis, and bacterial translocation in a model of systemic inflammation. J. Trauma. 32:1992;141.
32. Robertson R., Wallace B., Cone J. The role of the anti-inflammatory cytokines IL-4 and IL-10 in the systemic inflammatory response. Crit. Care Med. 24:1996;A87.
33. Heremans H., Van Damme J., Dillen C., Dijkmans R., Billiau A. Interferon gamma, a mediator of lethal lipopolysaccharide induced Shwartzman-like shock reactions in mice. J. Exp. Med. 71:1990;1853.
34. Cody R. P., Smith J. K. Applied Statistics and the SAS Programming Language. 1991;Elsevier Science, North-Holland, New York.
35. Kleinbaum D. G., Kupper L. L. Applied Regression Analysis and Other Multivariable Methods. 1978;Duxbury Press, (Wadsworth).
36. Casey L. C., Balk R. A., Bone R. C. Plasma cytokine and endotoxin levels correlate with survival in patients with sepsis syndrome. Ann. Intern. Med. 119:1993;771.
37. Wherry J., Wenzel R., Abraham A. A controlled randomized double blind clinical trial of monoclonal antibody to human tumor necrosis factor (TNF Mab) in patients with sepsis syndrome. Chest. 104:1993;48s.
38. Waage A., Halstensen A., Espevik T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet. 1:1987;355.
39. Rogy M. A., Coyle S. M., Oldenburg H. S. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients. J. Am. Coll. Surg. 178:1994;132.
40. Remick D. A., Friedland J. S. Cytokines in Health and Disease. 1997;Marcel Dekker, New York.
41. Goris R. J. A., te Boekhorst T. P. A., Nuytinck J. K. S., Gimbrere J. S. F. Multiple-organ failure. Arch. Surg. 120:1985;1109.
42. Pinsky M. R., Matuschak G. M. A unifying hypothesis of multiple systems organ failure: Failure of host defense homeostasis. J. Crit. Care. 5:1990;108.